跳转至内容
Merck
CN

1359903

USP

左卡尼汀

United States Pharmacopeia (USP) Reference Standard

别名:

L -肉碱 内盐, 左旋肉毒碱, 维生素 BT

登录查看公司和协议定价


About This Item

线性分子式:
(CH3)3N+CH2CH(OH)CH2COO-
CAS号:
分子量:
161.20
Beilstein:
4292315
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

levocarnitine

制造商/商品名称

USP

mp

197-212 °C (lit.)

应用

pharmaceutical (small molecule)

包装形式

neat

SMILES字符串

C[N+](C)(C)C[C@H](O)CC([O-])=O

InChI

1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1

InChI key

PHIQHXFUZVPYII-ZCFIWIBFSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

本产品按照发行药典的发行和规定提供。支持本产品的所有信息,包括安全数据表和任何产品信息传单,都是在发行药典的授权下开发和发布的。如需进一步的信息和支持,请访问发行药典网站。如需进一步信息和支持,请访问现行药典网站。

应用

左旋肉碱USP参考标准品设计用于USP规定的指定质量测试和分析。
也用于下列USP专论方法:
  • 左旋肉碱片
  • 左旋肉碱注射液
  • 左旋肉碱口服溶液

生化/生理作用

肉毒碱是一种天然存在于大多数哺乳动物组织中的季铵。它在骨骼肌和心脏中参与能量代谢调控,浓度相对较高。它可将葡萄糖代谢由糖酵解转移至糖原储存,并促进长链脂肪酸向线粒体转运,使其在线粒体氧化产生能量。

分析说明

这些产品仅供测试和分析使用。它们不适用于人类或动物的给药,不可用于诊断、治疗或治愈任何疾病。

其他说明

可能适用相应的销售限制。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Marieke G Schooneman et al.
Biochimica et biophysica acta, 1841(7), 987-994 (2014-04-22)
Acylcarnitines have been linked to obesity-induced insulin resistance. However the majority of these studies have focused on acylcarnitines in plasma. It is currently unclear to what extent plasma levels of acylcarnitines reflect tissue acylcarnitine metabolism. We investigated the correlation of
Reese H Clark et al.
Pediatrics, 134(1), e37-e46 (2014-06-11)
To describe the influence that gestational age and chronological age have on amino acid and acylcarnitine profiles in an at-risk population of premature infants. Metabolic profiles (15 amino acids and 35 acylcarnitines) were obtained by using standard newborn techniques on
P D Pion et al.
The Veterinary clinics of North America. Small animal practice, 28(6), 1495-1514 (1999-03-31)
In this article, the current state of knowledge of the potential role of taurine and L-carnitine deficiency and supplementation in the genesis and management of cardiovascular disease in dogs is presented. There is limited direct evidence to support the recommendations
Allan Evans
American journal of kidney diseases : the official journal of the National Kidney Foundation, 41(4 Suppl 4), S13-S26 (2003-05-17)
Among the homeostatic processes controlling the endogenous L-carnitine pool in humans, the kidney has a vital role through extensive and adaptive tubular reabsorption. Kidney disease can lead to disturbances in L-carnitine homeostasis, and long-term hemodialysis therapy can lead to a
Yasuro Furuichi et al.
Biochimica et biophysica acta, 1837(10), 1699-1706 (2014-06-03)
Carnitine is well recognized as a key regulator of long-chain fatty acyl group translocation into the mitochondria. In addition, carnitine, as acetylcarnitine, acts as an acceptor of excess acetyl-CoA, a potent inhibitor of pyruvate dehydrogenase. Here, we provide a new

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门